Novelix Pharmaceuticals Ltd — Important, 12-02-2026: Company Update

Novelix Pharmaceuticals submitted its fund utilization statement for the quarter ended December 31, 2025. The company raised a total of Rs. 6.42 crore across three separate instances, earmarked for long-term funding, working capital, and general corporate needs to support future growth. While the company declared no deviation in how these funds were used, the report showed NIL utilization of the raised capital during this specific quarter. The Audit Committee reviewed the statement with no further comments.